Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Effects of human plasma proteins on maturation of monocyte-derived dendritic cells

Z Tobiasova-Czetoova, A Palmborg, A Lundqvist, G Karlsson, L Adamson, J Bartunkova, G Masucci, P Pisa

. 2005 ; 100 (2) : 113-119.

Jazyk angličtina Země Nizozemsko

Typ dokumentu srovnávací studie, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S.

Perzistentní odkaz   https://www.medvik.cz/link/bmc13025427

Grantová podpora
NI7537 MZ0 CEP - Centrální evidence projektů

Dendritic cells (DC) are a promising tool for vaccine therapy due to their unique properties as antigen presenting cells and their ability to prime naive T cells. Increasing evidence suggests that maturation stage of DC critically influences the fate of the immune response. Generation of monocyte-derived DC for clinically applicable immunotherapy requires the use of well-defined components and stringent culture conditions. An alternative strategy is to use human autologous serum. However, its constituents are not stable and reflect the inflammatory condition of the donor. In order to investigate whether DC properties are influenced by proteins present in the plasma, we matured human monocyte-derived DC with four main plasma components: fibrinogen, fibronectin, plasminogen or C-reactive protein. These purified proteins were added at various concentrations on day 6 after the initial differentiation induced by IL-4 and GM-CSF. The maturation was assessed by phenotyping of maturation-associated marker (CD83) and co-stimulatory molecule CD86 as well as IL-12 production. Functional properties of DC were assessed by endocytic activity and mixed leukocyte culture. Our results indicate that fibrinogen had DC-maturation effect comparable to poly-I:C, TNF-alpha and PGE(2) as a positive control, but it failed to induce IL-12 production. The other plasma proteins had no effect on DC maturation. CRP at high concentration had rather inhibitory effect on DC induced lymphocyte function. We conclude that none of the tested plasma components and acute phase proteins sufficiently induce fully competent mature DC. This finding is important for the preparation of human DC-based vaccines supplemented by autologous sera.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc13025427
003      
CZ-PrNML
005      
20130813142941.0
007      
ta
008      
130722s2005 ne d f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.imlet.2005.03.009 $2 doi
035    __
$a (PubMed)16154491
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a ne
100    1_
$a Tobiásová-Czetöová, Z. $7 _AN074001 $u Department of Immunology, 2nd Medical Faculty and Faculty Hospital Motol, Prague, Czech Republic
245    10
$a Effects of human plasma proteins on maturation of monocyte-derived dendritic cells / $c Z Tobiasova-Czetoova, A Palmborg, A Lundqvist, G Karlsson, L Adamson, J Bartunkova, G Masucci, P Pisa
504    __
$a Literatura
520    9_
$a Dendritic cells (DC) are a promising tool for vaccine therapy due to their unique properties as antigen presenting cells and their ability to prime naive T cells. Increasing evidence suggests that maturation stage of DC critically influences the fate of the immune response. Generation of monocyte-derived DC for clinically applicable immunotherapy requires the use of well-defined components and stringent culture conditions. An alternative strategy is to use human autologous serum. However, its constituents are not stable and reflect the inflammatory condition of the donor. In order to investigate whether DC properties are influenced by proteins present in the plasma, we matured human monocyte-derived DC with four main plasma components: fibrinogen, fibronectin, plasminogen or C-reactive protein. These purified proteins were added at various concentrations on day 6 after the initial differentiation induced by IL-4 and GM-CSF. The maturation was assessed by phenotyping of maturation-associated marker (CD83) and co-stimulatory molecule CD86 as well as IL-12 production. Functional properties of DC were assessed by endocytic activity and mixed leukocyte culture. Our results indicate that fibrinogen had DC-maturation effect comparable to poly-I:C, TNF-alpha and PGE(2) as a positive control, but it failed to induce IL-12 production. The other plasma proteins had no effect on DC maturation. CRP at high concentration had rather inhibitory effect on DC induced lymphocyte function. We conclude that none of the tested plasma components and acute phase proteins sufficiently induce fully competent mature DC. This finding is important for the preparation of human DC-based vaccines supplemented by autologous sera.
590    __
$a bohemika - dle Pubmed
650    02
$a CD antigeny $x analýza $7 D015703
650    12
$a krevní proteiny $x farmakologie $7 D001798
650    02
$a buněčná diferenciace $x účinky léků $7 D002454
650    02
$a kultivované buňky $7 D002478
650    12
$a dendritické buňky $x imunologie $x účinky léků $7 D003713
650    02
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    02
$a fibrinogen $x farmakologie $7 D005340
650    02
$a lidé $7 D006801
650    02
$a imunoglobuliny $x analýza $7 D007136
650    02
$a imunofenotypizace $7 D016130
650    02
$a test smíšené lymfocytární kultury $7 D007959
650    02
$a melanom $x krev $7 D008545
650    02
$a membránové glykoproteiny $x analýza $7 D008562
650    12
$a monocyty $x imunologie $x účinky léků $7 D009000
655    _2
$a srovnávací studie $7 D003160
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
700    1_
$a Palmborg, A.
700    1_
$a Lundqvist, A.
700    1_
$a Karlsson, G.
700    1_
$a Adamson, L. $7 gn_A_00001624
700    1_
$a Bartůňková, Jiřina, $d 1958- $7 jn20000400093 $u Department of Immunology, 2nd Medical Faculty and Faculty Hospital Motol, Prague, Czech Republic
700    1_
$a Masucci, G.
700    1_
$a Pisa P
773    0_
$t Immunology Letters $x 0165-2478 $g Roč. 100, č. 2 (2005), s. 113-119 $p Immunol Lett $w MED00002200
773    0_
$p Immunol Lett $g 100(2):113-9, 2005 Sep 15 $x 0165-2478
910    __
$a ABA008 $b B 1588 $y 3 $z 0
990    __
$a 20130722144420 $b ABA008
991    __
$a 20130813143449 $b ABA008
999    __
$a ok $b bmc $g 989240 $s 823827
BAS    __
$a 3
BMC    __
$a 2005 $b 100 $c 2 $d 113-119 $i 0165-2478 $m Immunology letters $x MED00002200 $n Immunol Lett
GRA    __
$a NI7537 $p MZ0
LZP    __
$a 2013-07/dpbo

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...